Insmed Depreciation decreased by 19.0% to $2.93M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.8%, from $1.88M to $2.93M. Over 4 years (FY 2021 to FY 2025), Depreciation shows an upward trend with a 3.4% CAGR.
High depreciation relative to revenue may indicate a capital-intensive business model or significant recent investment in infrastructure.
The systematic allocation of the cost of tangible assets over their useful lives. This non-cash expense reflects the wea...
Standard accounting metric across all capital-intensive industries.
other_depreciation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39M | $2.24M | $2.12M | $1.29M | $958.00K | $851.00K | $2.18M | $1.25M | $1.31M | $1.49M | $1.48M | $1.59M | $1.44M | $1.46M | $1.48M | $1.88M | $2.48M | $2.46M | $3.62M | $2.93M |
| QoQ Change | — | -6.2% | -5.3% | -39.3% | -25.5% | -11.2% | +156.5% | -42.8% | +5.0% | +13.9% | -1.2% | +7.7% | -9.6% | +1.6% | +1.3% | +27.4% | +31.9% | -1.0% | +47.4% | -19.0% |
| YoY Change | — | — | — | — | -59.8% | -62.0% | +3.0% | -3.0% | +36.8% | +75.4% | -32.4% | +27.2% | +9.5% | -2.3% | +0.2% | +18.6% | +73.0% | +68.5% | +145.2% | +55.8% |